Azenta, Inc. (AZTA)
Burlington, MA, US
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Based on only 1 article — low confidence
- Azenta Completes Sale of B Medical Systems PRNewsWire
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.34% | -5.60% | -24.86% | -38.75% | -41.33% | -47.29% | -37.17% | -56.85% | -80.43% | +89.92% | +75.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | -1 |
| Buy | 2 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 6 |
42.50
+63.1%
|
| All Time | 9 |
51.00
+95.8%
|
-
Revenue growth Medical - Instruments & Supplies: +7.9%+3.6% Q1'26: +1.0% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+60.5% ★ Q1'26: -296.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+4.9% Q1'26: +3.3% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-1.2% Q1'26: -10.6% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-0.5% Q1'26: -5.0% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-13.7% ★ Q1'26: +0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×2.06× ★ Q1'26: -10.65× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2015 actual |
Sep 2016 actual |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 4 Rev. Ana. 3 EPS Ana. |
Sep 2027 4 Rev. Ana. 2 EPS Ana. |
Sep 2028 4 Rev. Ana. 2 EPS Ana. |
Sep 2029 2 Rev. Ana. 1 EPS Ana. |
Sep 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
552.71M
est: 550.33M (+0.4%)
|
560.32M
est: 551.90M (+1.5%)
|
527.50M
est: 685.66M (-23.1%)
|
631.56M
est: 825.70M (-23.5%)
|
780.85M
est: 777.00M (+0.5%)
|
388.54M
est: 885.15M (-56.1%)
|
513.70M
est: 1.19B (-56.8%)
|
555.50M
est: 551.68M (+0.7%)
|
665.07M
est: 641.02M (+3.8%)
|
573.45M
est: 655.38M (-12.5%)
|
593.82M
est: 591.02M (+0.5%)
|
600.45M
589.60M – 603.84M
+1.6% YoY
|
629.52M
618.14M – 633.07M
+4.8% YoY
|
675.03M
662.83M – 678.83M
+7.2% YoY
|
683.50M
671.15M – 687.36M
+1.3% YoY
|
742.80M
729.38M – 746.99M
+8.7% YoY
|
| EBITDA |
43.37M
est: 18.86M (+130.0%)
|
32.16M
est: 18.91M (+70.1%)
|
42.13M
est: 23.49M (+79.3%)
|
66.69M
est: 28.29M (+135.7%)
|
86.14M
est: 26.62M (+223.6%)
|
28.15M
est: 30.33M (-7.2%)
|
9.94M
est: 40.71M (-75.6%)
|
48.36M
est: 18.90M (+155.8%)
|
55.15M
est: 21.96M (+151.1%)
|
71.62M
est: 114.79M (-37.6%)
|
54.07M
est: 103.52M (-47.8%)
|
105.17M
103.27M – 105.76M
+1.6% YoY
|
110.26M
108.27M – 110.88M
+4.8% YoY
|
118.23M
116.09M – 118.90M
+7.2% YoY
|
119.72M
117.55M – 120.39M
+1.3% YoY
|
130.10M
127.75M – 130.84M
+8.7% YoY
|
| EBIT |
18.21M
est: -43.82M (+141.6%)
|
4.11M
est: -43.94M (+109.4%)
|
14.93M
est: -54.59M (+127.3%)
|
29.99M
est: -65.75M (+145.6%)
|
31.69M
est: -61.87M (+151.2%)
|
-37.35M
est: -70.48M (+47.0%)
|
-46.93M
est: -94.61M (+50.4%)
|
-5.35M
est: -43.93M (+87.8%)
|
-30.43M
est: -51.04M (+40.4%)
|
-19.13M
est: 33.14M (-157.7%)
|
-7.14M
est: 29.89M (-123.9%)
|
30.37M
29.82M – 30.54M
+1.6% YoY
|
31.84M
31.26M – 32.02M
+4.8% YoY
|
34.14M
33.52M – 34.33M
+7.2% YoY
|
34.57M
33.94M – 34.76M
+1.3% YoY
|
37.57M
36.89M – 37.78M
+8.7% YoY
|
| Net Income |
14.22M
est: 18.73M (-24.1%)
|
-69.48M
est: 18.56M (-474.2%)
|
62.61M
est: 54.07M (+15.8%)
|
116.58M
est: 71.15M (+63.8%)
|
28.82M
est: 35.04M (-17.8%)
|
64.85M
est: 52.83M (+22.8%)
|
110.75M
est: 116.18M (-4.7%)
|
-428.96M
est: 19.46M (-2,304.3%)
|
-14.26M
est: -12.81M (-11.3%)
|
-164.90M
est: 15.38M (-1,172.0%)
|
-55.76M
est: 22.89M (-343.6%)
|
20.41M
20.09M – 20.73M
-10.8% YoY
|
27.95M
27.52M – 28.39M
+37.0% YoY
|
38.90M
36.76M – 41.03M
+39.2% YoY
|
59.66M
58.26M – 60.10M
+53.4% YoY
|
80.78M
78.88M – 81.37M
+35.4% YoY
|
| SGA |
106.87M
est: 255.55M (-58.2%)
|
116.26M
est: 256.28M (-54.6%)
|
127.62M
est: 318.39M (-59.9%)
|
145.38M
est: 383.42M (-62.1%)
|
180.52M
est: 360.81M (-50.0%)
|
156.28M
est: 411.03M (-62.0%)
|
188.50M
est: 551.78M (-65.8%)
|
227.10M
est: 256.18M (-11.4%)
|
281.50M
est: 297.67M (-5.4%)
|
253.08M
est: 270.45M (-6.4%)
|
251.16M
est: 243.89M (+3.0%)
|
247.78M
243.30M – 249.18M
+1.6% YoY
|
259.78M
255.08M – 261.24M
+4.8% YoY
|
278.56M
273.52M – 280.13M
+7.2% YoY
|
282.05M
276.96M – 283.65M
+1.3% YoY
|
306.53M
300.99M – 308.25M
+8.7% YoY
|
| EPS |
0.21
est: 0.41 (-48.5%)
|
-1.02
est: 0.40 (-352.2%)
|
0.90
est: 1.18 (-23.6%)
|
1.65
est: 1.55 (+6.4%)
|
0.14
est: 0.76 (-81.7%)
|
0.88
est: 1.15 (-23.5%)
|
-0.39
est: 2.53 (-115.4%)
|
-0.15
est: 0.42 (-135.4%)
|
-0.22
est: -0.28 (+21.1%)
|
-3.09
est: 0.33 (-1,025.1%)
|
-1.22
est: 0.50 (-342.7%)
|
0.45
0.44 – 0.45
-10.8% YoY
|
0.61
0.60 – 0.62
+37.0% YoY
|
0.85
0.80 – 0.89
+38.0% YoY
|
1.30
1.27 – 1.31
+53.4% YoY
|
1.76
1.72 – 1.77
+35.4% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-06 | Needham | Buy | Buy | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group - 23-1945930 | 6.96M | 9.29% | — | 42.4K | 6.85M | 107.6K | IA | Pennsylvania | 2022-02-09 | ↗ |
| 2 | (1) BlackRock, Inc. | 6.12M | 13.40% | 5.96M | — | 6.12M | — | HC | Delaware | 2024-12-06 | ↗ |
| 3 | 752403190 | 5.99M | 8.76% | 3.26M | 2.74M | 5.99M | — | IA | A Delaware | 2016-02-02 | ↗ |
| 4 | Politan Capital Management GP LLC | 4.58M | 7.61% | — | 4.58M | — | 11.00 | IA | — | 2023-11-01 | ↗ |
| 5 | Politan Capital Management LP | 4.58M | 7.61% | — | 4.58M | — | 11.00 | IA | — | 2023-11-01 | ↗ |
| 6 | Politan Capital Partners GP LLC | 4.58M | 7.61% | — | 4.58M | — | 11.00 | IA | — | 2023-11-01 | ↗ |
| 7 | Quentin Koffey | 4.58M | 7.61% | — | 4.58M | — | 11.00 | IN | — | 2023-11-01 | ↗ |
| 8 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC95-4575414 | 4.13M | 5.52% | 2.06M | 1.64M | 2.50M | 1.64M | IA | — | 2022-02-11 | ↗ |
| 9 | William Blair Investment Management, LLC | 3.72M | 5.00% | 3.32M | — | 3.72M | — | IA | Delaware | 2022-02-10 | ↗ |
| 10 | D.F. Dent and Company, Inc. | 3.58M | 4.96% | 3.58M | — | 3.58M | — | IA | State of Maryland | 2019-11-08 | ↗ |
| 11 | (. | 3.35M | 4.65% | 3.21M | — | 3.35M | — | IA | Delaware Limited Partnership | 2019-02-08 | ↗ |
| 12 | 52-2343049 | 3.07M | 4.53% | 3.07M | — | 3.07M | — | IA | New York | 2016-02-03 | ↗ |
| 13 | 30-0447847 | 3.01M | 6.10% | 2.95M | — | 3.01M | — | IA | Delaware | 2024-10-31 | ↗ |
| 14 | Race & Zollo, Inc. | — | 0.00% | — | — | — | — | IA | State of Florida | 2015-02-06 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 42.3K +42.3K (+100.0%) | 1.41B +1.4B (+100.0%) | 0.09% +0.092 pp | 0.00% +0.002 pp | USD33.26 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 6.78M -123.7K (-1.8%) | 225.51M +27.2M (+13.7%) | 14.76% -0.341 pp | 0.00% +0.000 pp | USD43.75 -24.0% | 6 qtrs — |
| 3 | POLITAN CAPITAL MANAGEMENT LP | 4.62M +— (+0.0%) | 153.55M +21.0M (+15.8%) | 10.05% -0.048 pp | 18.27% +6.217 pp | USD48.91 -32.0% | 11 qtrs — |
| 4 | VANGUARD GROUP INC | 4.54M +99.6K (+2.2%) | 150.97M +23.5M (+18.4%) | 9.88% +0.171 pp | 0.00% +0.000 pp | USD41.38 -19.6% | 84 qtrs — |
| 5 | DIMENSIONAL FUND ADVISORS LP | 2.10M -420.4K (-16.7%) | 69.83M -2.5M (-3.5%) | 4.57% -0.941 pp | 0.01% -0.001 pp | USD46.53 -28.5% | 51 qtrs — |
| 6 | MILLENNIUM MANAGEMENT LLC | 1.87M +168.0K (+9.9%) | 62.08M +13.3M (+27.3%) | 4.06% +0.348 pp | 0.03% +0.005 pp | USD32.13 +3.5% | 43 qtrs — |
| 7 | STATE STREET CORP | 1.73M +24.1K (+1.4%) | 57.63M +8.6M (+17.4%) | 3.77% +0.035 pp | 0.00% +0.000 pp | USD26.45 +25.7% | 51 qtrs — |
| 8 | GW&K INVESTMENT MANAGEMENT, LLC | 1.55M +419.6K (+37.1%) | 51.56M +19.1M (+58.8%) | 3.38% +0.902 pp | 0.45% +0.159 pp | USD57.47 -42.1% | 21 qtrs — |
| 9 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 1.39M +99.9K (+7.8%) | 46.35M +5.7M (+13.9%) | 3.02% +0.204 pp | 0.08% +0.010 pp | USD56.02 -40.6% | 17 qtrs — |
| 10 | CONESTOGA CAPITAL ADVISORS, LLC | 1.32M -151.6K (-10.3%) | 43.78M +1.6M (+3.8%) | 2.87% -0.345 pp | 0.74% +0.060 pp | USD68.02 -51.1% | 19 qtrs — |
| 11 | CONGRESS ASSET MANAGEMENT CO /MA | 1.29M +1.3M (+100.0%) | 42.75M +42.8M (+100.0%) | 2.80% +2.799 pp | 0.30% +0.301 pp | USD33.26 +0.0% | 1 qtrs NEW |
| 12 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.11M +1.1M (+100.0%) | 36.80M +36.8M (+100.0%) | 2.41% +2.409 pp | 0.01% +0.012 pp | USD33.26 +0.0% | 1 qtrs NEW |
| 13 | STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 1.07M +106.2K (+11.0%) | 35.66M +7.9M (+28.5%) | 2.33% +0.221 pp | 0.46% +0.105 pp | USD65.24 -49.0% | 19 qtrs — |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 1.02M +1.2K (+0.1%) | 34.02M +4.7M (+15.9%) | 2.23% -0.008 pp | 0.00% +0.000 pp | USD35.76 -7.0% | 78 qtrs — |
| 15 | AMERICAN CAPITAL MANAGEMENT INC | 1.02M +192.1K (+23.2%) | 33.97M +10.2M (+42.6%) | 2.22% +0.410 pp | 1.50% +0.550 pp | USD59.63 -44.2% | 19 qtrs — |
| 16 | MORGAN STANLEY | 913.2K -28.2K (-3.0%) | 30.37M +3.3M (+12.3%) | 1.99% -0.071 pp | 0.00% +0.000 pp | USD43.47 -23.5% | 51 qtrs — |
| 17 | PARK WEST ASSET MANAGEMENT LLC | 700.0K +256.5K (+57.8%) | 23.28M +10.5M (+82.8%) | 1.52% +0.554 pp | 1.93% +0.860 pp | USD36.45 -8.8% | 5 qtrs — |
| 18 | PALISADE CAPITAL MANAGEMENT, LP | 678.2K -124.2K (-15.5%) | 22.56M -488.5K (-2.1%) | 1.48% -0.279 pp | 0.67% +0.042 pp | USD48.25 -31.1% | 26 qtrs — |
| 19 | GOLDMAN SACHS GROUP INC | 626.3K +148.9K (+31.2%) | 20.83M +7.1M (+51.9%) | 1.36% +0.319 pp | 0.00% +0.001 pp | USD33.83 -1.7% | 40 qtrs — |
| 20 | FEDERATED HERMES, INC. | 623.7K -66.7K (-9.7%) | 20.74M +916.8K (+4.6%) | 1.36% -0.152 pp | 0.03% 0.000 pp | USD46.11 -27.9% | 54 qtrs — |
| 21 | AMERIPRISE FINANCIAL INC | 618.7K -2.1K (-0.3%) | 20.58M +2.7M (+15.4%) | 1.35% -0.011 pp | 0.00% +0.001 pp | USD38.39 -13.4% | 55 qtrs — |
| 22 | QUANTINNO CAPITAL MANAGEMENT LP | 618.0K -42.3K (-6.4%) | 20.56M +1.6M (+8.4%) | 1.35% -0.099 pp | 0.04% -0.011 pp | USD32.55 +2.2% | 8 qtrs — |
| 23 | LORD, ABBETT & CO. LLC | 614.5K +50.1K (+8.9%) | 20.44M +4.2M (+26.1%) | 1.34% +0.103 pp | 0.06% +0.014 pp | USD46.60 -28.6% | 5 qtrs — |
| 24 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 569.1K +28.7K (+5.3%) | 18.93M +3.4M (+22.0%) | 1.24% +0.057 pp | 0.97% +0.064 pp | USD51.88 -35.9% | 15 qtrs — |
| 25 | SCOPIA CAPITAL MANAGEMENT LP | 566.7K +78.4K (+16.0%) | 18.85M +4.8M (+34.4%) | 1.23% +0.166 pp | 3.89% +2.131 pp | USD29.35 +13.3% | 2 qtrs — |
| 26 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 562.6K -308.0 (-0.1%) | 18.71M +2.5M (+15.7%) | 1.22% -0.007 pp | 0.00% +0.000 pp | USD30.07 +10.6% | 92 qtrs — |
| 27 | SEGALL BRYANT & HAMILL, LLC | 556.0K +14.2K (+2.6%) | 18.49M +2.9M (+18.8%) | 1.21% +0.025 pp | 0.25% +0.043 pp | USD40.98 -18.8% | 16 qtrs — |
| 28 | ROYAL BANK OF CANADA | 521.7K -73.3K (-12.3%) | 17.35M +261.0K (+1.5%) | 1.14% -0.166 pp | 0.00% +0.000 pp | USD41.57 -20.0% | 51 qtrs — |
| 29 | D. E. SHAW & CO., INC. | 520.2K +383.4K (+280.4%) | 17.30M +13.4M (+340.5%) | 1.13% +0.833 pp | 0.01% +0.007 pp | USD37.57 -11.5% | 20 qtrs — |
| 30 | GOTHAM ASSET MANAGEMENT, LLC | 505.0K -27.3K (-5.1%) | 16.80M +1.5M (+9.9%) | 1.10% -0.065 pp | 0.06% -0.005 pp | USD30.89 +7.7% | 25 qtrs — |
| 31 | NUVEEN, LLC | 470.7K -225.3K (-32.4%) | 15.66M -4.3M (-21.7%) | 1.02% -0.498 pp | 0.00% -0.001 pp | USD32.55 +2.2% | 4 qtrs — |
| 32 | GENEVA CAPITAL MANAGEMENT LLC | 463.4K -52.5K (-10.2%) | 15.41M +597.0K (+4.0%) | 1.01% -0.120 pp | 0.29% +0.035 pp | USD69.21 -51.9% | 21 qtrs — |
| 33 | NORTHERN TRUST CORP | 452.3K -28.3K (-5.9%) | 15.04M +1.2M (+9.0%) | 0.98% -0.067 pp | 0.00% +0.000 pp | USD26.13 +27.3% | 51 qtrs — |
| 34 | SCHRODER INVESTMENT MANAGEMENT GROUP | 438.9K -7.4K (-1.7%) | 14.92M +2.4M (+18.7%) | 0.96% -0.021 pp | 0.01% +0.002 pp | USD56.26 -40.9% | 15 qtrs — |
| 35 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 446.2K -5.6K (-1.2%) | 14.84M +1.9M (+14.4%) | 0.97% -0.017 pp | 0.35% +0.034 pp | USD54.70 -39.2% | 51 qtrs — |
| 36 | BANK OF AMERICA CORP /DE/ | 415.3K -94.7K (-18.6%) | 13.81M -833.9K (-5.7%) | 0.90% -0.211 pp | 0.00% +0.000 pp | USD44.85 -25.8% | 52 qtrs — |
| 37 | VICTORY CAPITAL MANAGEMENT INC | 380.3K +380.3K (+100.0%) | 12.65M +12.6M (+100.0%) | 0.83% +0.828 pp | 0.01% +0.007 pp | USD33.26 +0.0% | 45 qtrs — |
| 38 | BANK OF NEW YORK MELLON CORP | 337.3K -7.4K (-2.2%) | 11.22M +1.3M (+13.3%) | 0.73% -0.020 pp | 0.00% +0.000 pp | USD20.86 +59.4% | 66 qtrs — |
| 39 | UBS GROUP AG | 326.7K -4.0K (-1.2%) | 10.86M +1.4M (+14.4%) | 0.71% -0.012 pp | 0.00% +0.000 pp | USD43.69 -23.9% | 45 qtrs — |
| 40 | FRONT STREET CAPITAL MANAGEMENT, INC. | 285.3K +35.3K (+14.1%) | 9.49M +2.3M (+32.1%) | 0.62% +0.074 pp | 1.35% +0.239 pp | USD29.72 +11.9% | 3 qtrs — |
| 41 | CITADEL ADVISORS LLC | 279.9K +119.2K (+74.2%) | 9.31M +4.7M (+101.7%) | 0.61% +0.258 pp | 0.00% +0.001 pp | USD34.93 -4.8% | 42 qtrs — |
| 42 | NEW YORK STATE COMMON RETIREMENT FUND | 270.9K -981.0 (-0.4%) | 9.01M +1.2M (+15.4%) | 0.59% -0.005 pp | 0.01% +0.002 pp | USD53.58 -37.9% | 88 qtrs — |
| 43 | MAN GROUP PLC | 253.3K +21.8K (+9.4%) | 8.42M +1.8M (+26.7%) | 0.55% +0.045 pp | 0.01% +0.003 pp | USD32.33 +2.9% | 29 qtrs — |
| 44 | NORDEA INVESTMENT MANAGEMENT AB | 238.9K -29.7K (-11.1%) | 8.01M +470.0K (+6.2%) | 0.52% -0.067 pp | 0.01% +0.000 pp | USD45.63 -27.1% | 18 qtrs — |
| 45 | INVESCO LTD. | 232.2K -5.0K (-2.1%) | 7.72M +912.0K (+13.4%) | 0.51% -0.013 pp | 0.00% +0.000 pp | USD48.77 -31.8% | 57 qtrs — |
| 46 | GRANAHAN INVESTMENT MANAGEMENT, LLC | 204.7K +194.9K (+1,999.7%) | 6.81M +6.5M (+2,331.6%) | 0.45% +0.424 pp | 0.29% +0.280 pp | USD33.13 +0.4% | 3 qtrs — |
| 47 | PRINCIPAL FINANCIAL GROUP INC | 194.4K -2.6K (-1.3%) | 6.47M +809.4K (+14.3%) | 0.42% -0.008 pp | 0.00% +0.000 pp | USD36.08 -7.8% | 81 qtrs — |
| 48 | SEI INVESTMENTS CO | 183.6K +29.6K (+19.2%) | 6.11M +1.7M (+38.0%) | 0.40% +0.063 pp | 0.01% +0.001 pp | USD56.75 -41.4% | 34 qtrs — |
| 49 | ROUBAIX CAPITAL, LLC | 183.6K +162.0K (+751.0%) | 6.11M +5.5M (+885.5%) | 0.40% +0.353 pp | 2.60% +2.315 pp | USD32.73 +1.6% | 2 qtrs — |
| 50 | MEROS INVESTMENT MANAGEMENT, LP | 166.8K +6.9K (+4.3%) | 5.55M +955.6K (+20.8%) | 0.36% +0.013 pp | 2.20% +0.239 pp | USD28.91 +15.0% | 2 qtrs — |
| 51 | COMERICA BANK | 161.7K -3.4K (-2.0%) | 5.38M +637.7K (+13.4%) | 0.35% -0.009 pp | 0.02% +0.004 pp | USD47.40 -29.8% | 10 qtrs — |
| 52 | PEREGRINE CAPITAL MANAGEMENT LLC | 151.0K -2.1K (-1.3%) | 5.02M +626.6K (+14.3%) | 0.33% -0.006 pp | 0.15% +0.022 pp | USD62.16 -46.5% | 15 qtrs — |
| 53 | SQUAREPOINT OPS LLC | 148.2K +67.7K (+84.2%) | 4.93M +2.6M (+113.3%) | 0.32% +0.147 pp | 0.01% +0.003 pp | USD38.94 -14.6% | 19 qtrs — |
| 54 | JUPITER ASSET MANAGEMENT LTD | 144.8K -7.0K (-4.6%) | 4.82M +455.9K (+10.5%) | 0.32% -0.017 pp | 0.04% +0.001 pp | USD31.60 +5.3% | 4 qtrs — |
| 55 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 141.8K +— (+0.0%) | 4.72M +643.9K (+15.8%) | 0.31% -0.002 pp | 0.07% +0.008 pp | USD30.78 +8.1% | 3 qtrs — |
| 56 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 141.4K -17.8K (-11.2%) | 4.70M +131.8K (+2.9%) | 0.31% -0.040 pp | 0.02% -0.001 pp | USD45.23 -26.5% | 5 qtrs — |
| 57 | BALYASNY ASSET MANAGEMENT L.P. | 136.7K +136.7K (+100.0%) | 4.55M +4.5M (+100.0%) | 0.30% +0.298 pp | 0.01% +0.006 pp | USD33.26 +0.0% | 6 qtrs — |
| 58 | ADVISOR GROUP HOLDINGS, INC. | 134.0K +132.8K (+11,066.7%) | 4.46M +4.4M (+12,617.5%) | 0.29% +0.289 pp | 0.01% +0.007 pp | USD33.43 -0.5% | 24 qtrs — |
| 59 | UBS ASSET MANAGEMENT AMERICAS INC | 129.3K +7.3K (+6.0%) | 4.30M +798.1K (+22.8%) | 0.28% +0.015 pp | 0.00% +0.000 pp | USD39.21 -15.2% | 52 qtrs — |
| 60 | ENVESTNET ASSET MANAGEMENT INC | 127.8K +17.8K (+16.1%) | 4.25M +1.1M (+34.5%) | 0.28% +0.038 pp | 0.00% +0.000 pp | USD52.73 -36.9% | 34 qtrs — |
| 61 | SCHONFELD STRATEGIC ADVISORS LLC | 118.6K +106.1K (+849.9%) | 3.94M +3.6M (+1,000.1%) | 0.26% +0.231 pp | 0.02% +0.015 pp | USD33.20 +0.2% | 4 qtrs — |
| 62 | JPMORGAN CHASE & CO | 115.1K -358.3K (-75.7%) | 3.83M -9.8M (-71.8%) | 0.25% -0.785 pp | 0.00% -0.001 pp | USD51.17 -35.0% | 51 qtrs — |
| 63 | HRT FINANCIAL LP | 109.7K +34.8K (+46.6%) | 3.65M +1.5M (+69.8%) | 0.24% +0.075 pp | 0.01% +0.004 pp | USD30.16 +10.3% | 12 qtrs — |
| 64 | LEGAL & GENERAL GROUP PLC | 106.1K -299.1K (-73.8%) | 3.53M -8.1M (-69.7%) | 0.23% -0.656 pp | 0.00% -0.002 pp | USD42.85 -22.4% | 46 qtrs — |
| 65 | BARCLAYS PLC | 102.4K -67.1K (-39.6%) | 3.41M -4.8M (-58.5%) | 0.22% -0.148 pp | 0.00% -0.001 pp | USD39.21 -15.2% | 51 qtrs — |
| 66 | AMERICAN CENTURY COMPANIES INC | 101.0K -12.0K (-10.6%) | 3.36M +114.2K (+3.5%) | 0.22% -0.027 pp | 0.00% +0.000 pp | USD51.90 -35.9% | 20 qtrs — |
| 67 | RHUMBLINE ADVISERS | 98.7K -8.5K (-7.9%) | 3.28M +203.6K (+6.6%) | 0.21% -0.020 pp | 0.00% +0.000 pp | USD31.21 +6.6% | 55 qtrs — |
| 68 | ASSENAGON ASSET MANAGEMENT S.A. | 96.6K +69.0K (+249.4%) | 3.21M +2.4M (+304.6%) | 0.21% +0.150 pp | 0.00% +0.003 pp | USD31.96 +4.1% | 2 qtrs — |
| 69 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 94.3K -47.7K (-33.6%) | 3.13M -941.1K (-23.1%) | 0.21% -0.105 pp | 0.01% -0.005 pp | USD31.22 +6.5% | 4 qtrs — |
| 70 | PRUDENTIAL FINANCIAL INC | 82.5K +2.2K (+2.7%) | 2.74M +437.5K (+19.0%) | 0.18% +0.004 pp | 0.00% +0.001 pp | USD40.92 -18.7% | 85 qtrs — |
| 71 | SWISS NATIONAL BANK | 81.4K +1.5K (+1.9%) | 2.71M +412.6K (+18.0%) | 0.18% +0.002 pp | 0.00% +0.000 pp | USD25.85 +28.7% | 51 qtrs — |
| 72 | CAPITAL FUND MANAGEMENT S.A. | 80.5K -69.2K (-46.2%) | 2.68M -1.6M (-37.7%) | 0.18% -0.152 pp | 0.01% -0.004 pp | USD41.85 -20.5% | 6 qtrs — |
| 73 | RAYMOND JAMES FINANCIAL INC | 79.7K +47.0K (+143.2%) | 2.65M +1.7M (+181.7%) | 0.17% +0.102 pp | 0.00% +0.001 pp | USD39.94 -16.7% | 5 qtrs — |
| 74 | XTX TOPCO LTD | 68.6K +51.4K (+298.8%) | 2.28M +1.8M (+361.9%) | 0.15% +0.112 pp | 0.06% +0.034 pp | USD32.12 +3.5% | 10 qtrs — |
| 75 | CAXTON ASSOCIATES LLP | 68.5K +11.4K (+19.9%) | 2.28M +637.9K (+38.9%) | 0.15% +0.024 pp | 0.04% +0.006 pp | USD32.91 +1.1% | 4 qtrs — |
| 76 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 65.6K +— (+0.0%) | 2.18M +298.0K (+15.8%) | 0.14% -0.001 pp | 0.00% +0.001 pp | USD26.11 +27.4% | 51 qtrs — |
| 77 | RICE HALL JAMES & ASSOCIATES, LLC | 65.4K +25.7K (+64.9%) | 2.18M +1.0M (+91.0%) | 0.14% +0.056 pp | 0.12% +0.058 pp | USD32.68 +1.8% | 40 qtrs — |
| 78 | STATE OF WISCONSIN INVESTMENT BOARD | 63.9K -2.3K (-3.5%) | 2.13M +223.2K (+11.7%) | 0.14% -0.006 pp | 0.00% +0.000 pp | USD28.72 +15.8% | 32 qtrs — |
| 79 | SUMMIT TRAIL ADVISORS, LLC | 63.4K +4.5K (+7.6%) | 2.11M +415.5K (+24.6%) | 0.14% +0.009 pp | 0.04% +0.013 pp | USD30.95 +7.5% | 3 qtrs — |
| 80 | TREXQUANT INVESTMENT LP | 63.3K +28.4K (+81.4%) | 2.10M +1.1M (+110.0%) | 0.14% +0.061 pp | 0.02% +0.008 pp | USD30.76 +8.1% | 2 qtrs — |
| 81 | JOHN G ULLMAN & ASSOCIATES INC | 58.1K +5.5K (+10.5%) | 1.93M +421.8K (+27.9%) | 0.13% +0.011 pp | 0.26% +0.054 pp | USD34.26 -2.9% | 92 qtrs — |
| 82 | GSA CAPITAL PARTNERS LLP | 57.7K +47.8K (+482.7%) | 1.92M +1.6M (+573.7%) | 0.13% +0.104 pp | 0.17% +0.142 pp | USD32.48 +2.4% | 4 qtrs — |
| 83 | MERIDIEM CAPITAL PARTNERS LP | 57.7K +57.7K (+100.0%) | 1.92M +1.9M (+100.0%) | 0.13% +0.126 pp | 0.12% +0.116 pp | USD33.26 +0.0% | 3 qtrs — |
| 84 | ALLIANCEBERNSTEIN L.P. | 53.8K -2.4K (-4.2%) | 1.79M +176.4K (+10.9%) | 0.12% -0.006 pp | 0.00% +0.000 pp | USD42.54 -21.8% | 61 qtrs — |
| 85 | WELLS FARGO & COMPANY/MN | 52.7K +9.0K (+20.7%) | 1.75M +499.2K (+39.8%) | 0.11% +0.019 pp | 0.00% +0.000 pp | USD38.14 -12.8% | 57 qtrs — |
| 86 | AQR CAPITAL MANAGEMENT LLC | 52.5K -10.7K (-16.9%) | 1.75M -34.0K (-1.9%) | 0.11% -0.024 pp | 0.00% 0.000 pp | USD29.45 +12.9% | 3 qtrs — |
| 87 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 50.3K +11.7K (+30.5%) | 1.67M +565.7K (+51.1%) | 0.11% +0.025 pp | 0.00% +0.001 pp | USD34.11 -2.5% | 4 qtrs — |
| 88 | BRIDGEWATER ASSOCIATES, LP | 47.9K +47.9K (+100.0%) | 1.59M +1.6M (+100.0%) | 0.10% +0.104 pp | 0.01% +0.006 pp | USD33.26 +0.0% | 1 qtrs NEW |
| 89 | BOOTHBAY FUND MANAGEMENT, LLC | 46.6K +7.4K (+18.8%) | 1.55M +422.8K (+37.5%) | 0.10% +0.016 pp | 0.02% +0.007 pp | USD29.44 +13.0% | 2 qtrs — |
| 90 | PRICE T ROWE ASSOCIATES INC /MD/ | 42.0K +2.9K (+7.3%) | 1.40M +273.0K (+24.3%) | 0.09% +0.006 pp | 0.00% +0.000 pp | USD61.79 -46.2% | 75 qtrs — |
| 91 | BRINKER CAPITAL INVESTMENTS, LLC | 41.5K +4.8K (+13.1%) | 1.38M +326.2K (+31.0%) | 0.09% +0.010 pp | 0.01% +0.002 pp | USD54.35 -38.8% | 22 qtrs — |
| 92 | PARADIGM CAPITAL MANAGEMENT INC/NY | 40.9K +— (+0.0%) | 1.36M +185.7K (+15.8%) | 0.09% 0.000 pp | 0.06% +0.006 pp | USD15.05 +121.0% | 52 qtrs — |
| 93 | LPL FINANCIAL LLC | 40.3K +1.1K (+2.7%) | 1.34M +213.9K (+19.0%) | 0.09% +0.002 pp | 0.00% +0.000 pp | USD56.34 -41.0% | 34 qtrs — |
| 94 | WESBANCO BANK INC | 39.7K -11.0 (0.0%) | 1.32M +179.9K (+15.8%) | 0.09% 0.000 pp | 0.04% +0.005 pp | USD47.61 -30.1% | 8 qtrs — |
| 95 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 38.9K +13.0 (+0.0%) | 1.30M +177.2K (+15.8%) | 0.08% 0.000 pp | 0.00% +0.000 pp | USD24.48 +35.9% | 52 qtrs — |
| 96 | NISA INVESTMENT ADVISORS, LLC | 36.0K +36.0 (+0.1%) | 1.20M +164.4K (+15.9%) | 0.08% 0.000 pp | 0.00% +0.000 pp | USD48.69 -31.7% | 83 qtrs — |
| 97 | THRIVENT FINANCIAL FOR LUTHERANS | 35.4K -1.4K (-3.8%) | 1.18M +121.0K (+11.4%) | 0.08% -0.003 pp | 0.00% +0.000 pp | USD40.75 -18.4% | 66 qtrs — |
| 98 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 34.1K -10.8K (-24.0%) | 1.13M -128.0K (-10.1%) | 0.07% -0.024 pp | 0.00% +0.000 pp | USD54.38 -38.8% | 49 qtrs — |
| 99 | DEUTSCHE BANK AG\ | 34.0K +1.2K (+3.7%) | 1.13M +189.2K (+20.1%) | 0.07% +0.002 pp | 0.00% +0.000 pp | USD33.17 +0.3% | 50 qtrs — |
| 100 | QUBE RESEARCH & TECHNOLOGIES LTD | 33.6K +33.6K (+100.0%) | 1.12M +1.1M (+100.0%) | 0.07% +0.073 pp | 0.00% +0.001 pp | USD33.26 +0.0% | 1 qtrs NEW |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | MARTIN WILLIAM E. III | Officer | A-Award | A | Common | 17,790 | 24.24 | 431.2K | 17,790 | D | ↗ |
| 2026-04-06 | MARTIN WILLIAM E. III | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-02-06 | Nova Tina Susan | Director | A-Award | A | Common | 5,663 | 27.85 | 157.7K | 15,772 | D | ↗ |
| 2026-02-05 | McLaughlin Erica | Director | A-Award | A | Common | 5,663 | 27.85 | 157.7K | 22,521 | D | ↗ |
| 2026-02-05 | Madaus Martin D | Director | A-Award | A | Restricted Stock Unit | 5,663 | 0.00 | — | 9,703 | D | ↗ |
| 2026-02-05 | Doshi Dipal | Director | A-Award | A | Common | 5,663 | 27.85 | 157.7K | 9,703 | D | ↗ |
| 2026-02-05 | Davis Robyn C | Director | A-Award | A | Restricted Stock Unit | 5,663 | 0.00 | — | 23,662 | D | ↗ |
| 2026-02-05 | Cornog William L | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-02-05 | Casal Frank | Director | A-Award | A | Common | 7,243 | 27.85 | 201.7K | 21,803 | D | ↗ |
| 2025-11-24 | Zhou Ginger | Officer | A-Award | A | Common | 13,042 | 0.00 | — | 38,755 | D | ↗ |
| 2025-11-24 | Starr Ephraim | Officer | A-Award | A | Common | 34,235 | 0.00 | — | 72,014 | D | ↗ |
| 2025-11-24 | Pirogova Olga | Officer | A-Award | A | Common | 16,303 | 0.00 | — | 33,038 | D | ↗ |
| 2025-11-24 | Marotta John | Director / Officer | A-Award | A | Common | 122,269 | 0.00 | — | 217,269 | D | ↗ |
| 2025-11-24 | Lin Lawrence Y. | Officer | A-Award | A | Common | 36,681 | 0.00 | — | 79,655 | D | ↗ |
| 2025-11-14 | Zhou Ginger | Officer | F-InKind | D | Common | 1,118 | 29.75 | 33.3K | 25,713 | D | ↗ |
| 2025-11-14 | Pirogova Olga | Officer | F-InKind | D | Common | 1,553 | 29.75 | 46.2K | 16,735 | D | ↗ |
| 2025-11-14 | Marotta John | Director / Officer | F-InKind | D | Common | 10,980 | 29.75 | 326.7K | 95,000 | D | ↗ |
| 2025-11-14 | Lin Lawrence Y. | Officer | F-InKind | D | Common | 3,039 | 29.75 | 90.4K | 42,974 | D | ↗ |
| 2025-09-10 | Marotta John | Director / Officer | S-Sale | D | Common | 316 | 29.41 | 9.3K | 105,980 | D | ↗ |
| 2025-08-12 | Zhou Ginger | Officer | D-Return | D | Common | 1,085 | 28.54 | 31.0K | 26,831 | D | ↗ |
| 2025-08-12 | Pirogova Olga | Officer | S-Sale | D | Common | 1,085 | 28.54 | 31.0K | 18,288 | D | ↗ |
| 2025-08-11 | Lin Lawrence Y. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-02 | Marotta John | Director / Officer | P-Purchase | A | Common | 1,000 | 25.99 | 26.0K | 107,296 | D | ↗ |
| 2025-05-30 | Malus Alan J | Director | P-Purchase | A | Common | 12,000 | 26.65 | 319.8K | 17,035 | D | ↗ |
| 2025-05-20 | Cornog William L | Director | P-Purchase | A | Common | 2,748 | 27.37 | 75.2K | 25,795 | D | ↗ |
| 2025-05-19 | Cornog William L | Director | P-Purchase | A | Common | 4,152 | 26.98 | 112.0K | 23,047 | D | ↗ |
| 2025-05-16 | Cornog William L | Director | A-Award | A | Common | 100 | 26.50 | 2.7K | 14,855 | I | ↗ |
| 2025-05-15 | Starr Ephraim | Officer | A-Award | A | Common | 37,779 | 26.71 | 1.01M | 37,779 | D | ↗ |
| 2025-05-09 | Marotta John | Director / Officer | A-Award | A | Common | 1,796 | 27.84 | 50.0K | 106,296 | D | ↗ |
| 2025-05-09 | Lin Lawrence Y. | Officer | A-Award | A | Common | 4,000 | 27.49 | 110.0K | 43,513 | D | ↗ |
| 2025-05-08 | Marotta John | Director / Officer | A-Award | A | Common | 3,638 | 27.49 | 100.0K | 102,658 | D | ↗ |
| 2025-05-08 | Lin Lawrence Y. | Officer | A-Award | A | Common | 2,000 | 27.67 | 55.3K | 39,513 | D | ↗ |
| 2025-02-11 | Lin Lawrence Y. | Officer | A-Award | A | Common | 2,200 | 46.00 | 101.2K | 37,513 | D | ↗ |
| 2025-02-07 | Nova Tina Susan | Director | A-Award | A | Common | 4,040 | 52.32 | 211.4K | 10,109 | D | ↗ |
| 2025-02-07 | McLaughlin Erica | Director | A-Award | A | Common | 4,040 | 52.32 | 211.4K | 16,858 | D | ↗ |
| 2025-02-07 | Malus Alan J | Director | A-Award | A | Common | 4,040 | 52.32 | 211.4K | 5,035 | D | ↗ |
| 2025-02-07 | Madaus Martin D | Director | A-Award | A | Restricted Stock Unit | 4,040 | 0.00 | — | 4,040 | D | ↗ |
| 2025-02-07 | Koffey Quentin | Director | A-Award | A | Common Stock | 4,040 | 0.00 | — | 5,035 | D | ↗ |
| 2025-02-07 | Doshi Dipal | Director | A-Award | A | Common | 4,040 | 52.32 | 211.4K | 4,040 | D | ↗ |
| 2025-02-07 | Davis Robyn C | Director | A-Award | A | Common | 4,040 | 52.32 | 211.4K | 33,627 | D | ↗ |
| 2025-02-07 | Cornog William L | Director | A-Award | A | Restricted Stock Unit | 4,040 | 0.00 | — | 4,040 | D | ↗ |
| 2025-02-07 | Casal Frank | Director | A-Award | A | Common | 5,168 | 52.32 | 270.4K | 14,560 | D | ↗ |
| 2025-02-04 | Cornog William L | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-02-03 | Hughes Violetta | Officer | S-Sale | D | Common | 317 | 52.97 | 16.8K | 9,603 | D | ↗ |
| 2025-01-31 | Zhou Ginger | Officer | P-Purchase | A | Common | 417 | 45.88 | 19.1K | 27,916 | D | ↗ |
| 2025-01-31 | Doshi Dipal | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-05 | Lin Lawrence Y. | Officer | A-Award | A | Common | 5,768 | 45.00 | 259.6K | 35,313 | D | ↗ |
| 2024-12-04 | Wang David Dong | Officer | D-Return | D | Common | 140 | 46.65 | 6.5K | 23,974 | D | ↗ |
| 2024-11-28 | Lin Lawrence Y. | Officer | — | — | Common | 0 | 0.00 | — | 6,500 | D | ↗ |
| 2024-11-19 | Zhou Ginger | Officer | S-Sale | D | Common | 491 | 40.07 | 19.7K | 27,499 | D | ↗ |
| 2024-11-19 | Wang David Dong | Officer | S-Sale | D | Common | 348 | 40.07 | 13.9K | 24,114 | D | ↗ |
| 2024-11-19 | Pirogova Olga | Officer | S-Sale | D | Common | 548 | 40.07 | 22.0K | 19,373 | D | ↗ |
| 2024-11-19 | Marotta John | Director / Officer | P-Purchase | A | Common | 1,250 | 40.67 | 50.8K | 100,862 | D | ↗ |
| 2024-11-19 | Madaus Martin D | Director | P-Purchase | A | Common | 4,940 | 40.77 | 201.4K | 7,405 | D | ↗ |
| 2024-11-19 | Joseph Jason | Officer | S-Sale | D | Common | 1,139 | 40.07 | 45.6K | 112,564 | D | ↗ |
| 2024-11-19 | Hughes Violetta | Officer | S-Sale | D | Common | 163 | 40.07 | 6.5K | 9,920 | D | ↗ |
| 2024-11-19 | Cueto Herman | Officer | S-Sale | D | Common | 712 | 40.07 | 28.5K | 23,892 | D | ↗ |
| 2024-11-18 | Marotta John | Director / Officer | P-Purchase | A | Common | 12,717 | 39.48 | 502.1K | 99,612 | D | ↗ |
| 2024-11-18 | HIRSCH DIDIER | Director | P-Purchase | A | Common | 1,000 | 39.50 | 39.5K | 3,465 | D | ↗ |
| 2024-11-18 | Cornog William L | Director | P-Purchase | A | Common | 12,500 | 39.60 | 495.0K | 14,755 | I | ↗ |
| 2024-11-15 | Zhou Ginger | Officer | A-Award | A | Common | 8,651 | 41.51 | 359.1K | 27,990 | D | ↗ |
| 2024-11-15 | Wang David Dong | Officer | A-Award | A | Common | 8,651 | 41.51 | 359.1K | 24,462 | D | ↗ |
| 2024-11-15 | Pirogova Olga | Officer | A-Award | A | Common | 10,381 | 41.51 | 430.9K | 19,921 | D | ↗ |
| 2024-11-15 | Marotta John | Director / Officer | A-Award | A | Common | 83,622 | 41.51 | 3.47M | 86,895 | D | ↗ |
| 2024-11-15 | Joseph Jason | Officer | A-Award | A | Common | 13,841 | 41.51 | 574.5K | 113,703 | D | ↗ |
| 2024-11-15 | Hughes Violetta | Officer | A-Award | A | Common | 6,921 | 41.51 | 287.3K | 10,083 | D | ↗ |
| 2024-11-06 | Malus Alan J | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-11-06 | Koffey Quentin | Director | A-Award | A | Common Stock | 995 | 0.00 | — | 995 | D | ↗ |
| 2024-11-06 | Cornog William L | Director | D-Return | D | Common | 995 | 46.52 | 46.3K | 2,255 | D | ↗ |
| 2024-11-04 | Cornog William L | Director | — | — | Common | 0 | 0.00 | — | 1,260 | I | ↗ |
| 2024-11-01 | Politan Capital Management LP | Director | — | — | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 4,611,752 | I | ↗ |
| 2024-10-17 | Cueto Herman | Officer | S-Sale | D | Common | 1,595 | 43.68 | 69.7K | 24,604 | D | ↗ |
| 2024-09-09 | Marotta John | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-08-09 | Zhou Ginger | Officer | A-Award | A | Common | 6,333 | 55.27 | 350.0K | 19,339 | — | ↗ |
| 2024-08-09 | Wang David Dong | Officer | A-Award | A | Common | 6,333 | 55.27 | 350.0K | 15,811 | — | ↗ |
| 2024-08-09 | Pirogova Olga | Officer | A-Award | A | Common | 6,333 | 55.27 | 350.0K | 9,540 | — | ↗ |
| 2024-08-09 | Joseph Jason | Officer | A-Award | A | Common | 10,856 | 55.27 | 600.0K | 99,862 | — | ↗ |
| 2024-08-09 | Cueto Herman | Officer | A-Award | A | Common | 11,309 | 55.27 | 625.0K | 26,199 | — | ↗ |
| 2024-08-01 | Joseph Jason | Officer | D-Return | D | Common | 1,000 | 62.05 | 62.1K | 89,006 | — | ↗ |
| 2024-07-25 | Joseph Jason | Officer | D-Return | D | Common | 3,000 | 60.00 | 180.0K | 90,006 | — | ↗ |
| 2024-05-20 | Hughes Violetta | Officer | D-Return | D | Common | 584 | 51.36 | 30.0K | 3,162 | — | ↗ |
| 2024-04-01 | Joseph Jason | Officer | D-Return | D | Common | 1,000 | 60.15 | 60.2K | 93,006 | — | ↗ |
| 2024-03-08 | Joseph Jason | Officer | D-Return | D | Common | 4,000 | 67.50 | 270.0K | 94,006 | — | ↗ |
| 2024-03-07 | Joseph Jason | Officer | D-Return | D | Common | 1,000 | 65.21 | 65.2K | 106,006 | — | ↗ |
| 2024-02-12 | Rosenblatt Michael | Director | A-Award | A | Common | 2,465 | 65.93 | 162.5K | 13,042 | — | ↗ |
| 2024-02-12 | Nova Tina Susan | Director | A-Award | D | Common | 2,465 | 65.93 | 162.5K | 6,069 | — | ↗ |
| 2024-02-12 | McLaughlin Erica | Director | A-Award | A | Common | 2,465 | 65.93 | 162.5K | 12,818 | — | ↗ |
| 2024-02-12 | Madaus Martin D | Director | A-Award | A | Common | 2,465 | 65.93 | 162.5K | 2,465 | — | ↗ |
| 2024-02-12 | HIRSCH DIDIER | Director | A-Award | A | Common | 2,465 | 65.93 | 162.5K | 2,465 | — | ↗ |
| 2024-02-12 | Davis Robyn C | Director | A-Award | A | Common | 2,465 | 65.93 | 162.5K | 29,587 | — | ↗ |
| 2024-02-12 | Casal Frank | Director | A-Award | A | Common | 3,603 | 65.93 | 237.5K | 9,392 | — | ↗ |
| 2024-02-12 | Bousa Edward Peter | Director | A-Award | D | Common | 2,465 | 65.93 | 162.5K | 2,465 | — | ↗ |
| 2024-02-01 | Zhou Ginger | Officer | A-Award | A | Common | 448 | 39.41 | 17.7K | 12,942 | — | ↗ |
| 2024-02-01 | Vacha Robin | Officer | A-Award | A | Common | 324 | 39.41 | 12.8K | 31,287 | — | ↗ |
| 2024-01-31 | Zhou Ginger | Officer | A-Award | A | Common | 64 | 53.01 | 3.4K | 13,006 | — | ↗ |
| 2024-01-31 | Vacha Robin | Officer | A-Award | A | Common | 151 | 53.01 | 8.0K | 31,438 | — | ↗ |
| 2024-01-31 | Hughes Violetta | Officer | A-Award | D | Common | 311 | 65.20 | 20.3K | 3,746 | — | ↗ |
| 2024-01-30 | Madaus Martin D | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-01-30 | HIRSCH DIDIER | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-01-30 | Bousa Edward Peter | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-05 | Vacha Robin | Officer | D-Return | D | Common | 5,175 | 56.60 | 292.9K | 25,788 | — | ↗ |
| 2023-12-01 | Wang David Dong | Officer | D-Return | D | Common Stock | 138 | 57.96 | 8.0K | 9,478 | — | ↗ |
| 2023-11-17 | Gray David C | Officer | D-Return | D | Common Stock | 5,179 | 54.83 | 284.0K | 74,868 | — | ↗ |
| 2023-11-16 | Zhou Ginger | Officer | A-Award | A | Common Stock | 3,207 | 54.57 | 175.0K | 12,494 | — | ↗ |
| 2023-11-16 | Wang David Dong | Officer | A-Award | A | Common Stock | 3,207 | 54.57 | 175.0K | 9,616 | — | ↗ |
| 2023-11-16 | Vacha Robin | Officer | D-Return | D | Common Stock | 2,946 | 53.81 | 158.5K | 26,381 | — | ↗ |
| 2023-11-16 | SCHWARTZ STEPHEN S | Director / Officer | D-Return | D | Common Stock | 12,865 | 53.81 | 692.3K | 424,088 | — | ↗ |
| 2023-11-16 | Robertson Lindon G | Officer | D-Return | D | Common Stock | 2,779 | 53.81 | 149.5K | 121,081 | — | ↗ |
| 2023-11-16 | Pirogova Olga | Officer | A-Award | A | Common | 3,207 | 54.57 | 175.0K | 3,207 | — | ↗ |
| 2023-11-16 | Joseph Jason | Officer | A-Award | A | Common Stock | 5,498 | 54.57 | 300.0K | 107,006 | — | ↗ |
| 2023-11-16 | Hughes Violetta | Officer | A-Award | A | Common Stock | 1,374 | 54.57 | 75.0K | 4,057 | — | ↗ |
| 2023-11-16 | Gray David C | Officer | D-Return | D | Common Stock | 2,161 | 53.81 | 116.3K | 77,756 | — | ↗ |
| 2023-11-16 | Cueto Herman | Officer | A-Award | A | Common Stock | 5,727 | 54.57 | 312.5K | 5,727 | — | ↗ |
| 2023-11-15 | Zhou Ginger | Officer | A-Award | A | Common Stock | 877 | 54.13 | 47.5K | 9,745 | — | ↗ |
| 2023-11-15 | Vacha Robin | Officer | A-Award | A | Common Stock | 4,107 | 54.13 | 222.3K | 29,327 | — | ↗ |
| 2023-11-15 | SCHWARTZ STEPHEN S | Director / Officer | A-Award | A | Common Stock | 16,426 | 54.13 | 889.1K | 436,953 | — | ↗ |
| 2023-11-15 | Robertson Lindon G | Officer | A-Award | A | Common Stock | 6,297 | 54.13 | 340.9K | 123,860 | — | ↗ |
| 2023-11-15 | Joseph Jason | Officer | A-Award | A | Common Stock | 3,559 | 54.13 | 192.6K | 103,339 | — | ↗ |
| 2023-11-15 | Gray David C | Officer | A-Award | A | Common Stock | 2,875 | 54.13 | 155.6K | 79,917 | — | ↗ |
| 2023-11-10 | Wang David Dong | Officer | — | D | Common Stock | 0 | 0.00 | — | 5,000 | — | ↗ |
| 2023-11-10 | Pirogova Olga | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-16 | Cueto Herman | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-31 | Hughes Violetta | Officer | — | D | Common Stock | 0 | 0.00 | — | 2,683 | — | ↗ |
| 2023-08-11 | Gray David C | Officer | S-Sale | D | Common Stock | 10,877 | 56.03 | 609.4K | 70,610 | — | ↗ |
| 2023-08-10 | Vacha Robin | Officer | A-Award | D | Common Stock | 7,400 | 55.00 | 407.0K | 25,220 | — | ↗ |
| 2023-08-10 | Gray David C | Officer | S-Sale | D | Common Stock | 4,311 | 57.24 | 246.8K | 87,919 | — | ↗ |
| 2023-08-08 | Zane Ellen M | Director | A-Award | D | Common Stock | 18,766 | 55.78 | 1.05M | 41,134 | — | ↗ |
| 2023-07-31 | Zhou Ginger | Officer | A-Award | A | Common Stock | 54 | 39.98 | 2.2K | 8,868 | — | ↗ |
| 2023-07-31 | Vacha Robin | Officer | A-Award | A | Common Stock | 121 | 39.98 | 4.8K | 32,620 | — | ↗ |
| 2023-07-31 | Robertson Lindon G | Officer | A-Award | A | Common Stock | 105 | 39.98 | 4.2K | 117,563 | — | ↗ |
| 2023-06-06 | MARTIN JOSEPH R | Director | S-Sale | D | Common Stock | 2,400 | 43.07 | 103.4K | 85,175 | — | ↗ |
| 2023-02-13 | Zane Ellen M | Director | A-Award | A | Common Stock | 3,604 | 0.00 | — | 59,900 | — | ↗ |
| 2023-02-13 | Rosenblatt Michael | Director | A-Award | A | Common Stock | 3,604 | 0.00 | — | 10,577 | — | ↗ |
| 2023-02-13 | Palepu Krishna G. | Director | A-Award | A | Common Stock | 3,604 | 0.00 | — | 105,393 | — | ↗ |
| 2023-02-13 | PUHY DOROTHY E | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-02-13 | Nova Tina Susan | Director | A-Award | A | Common Stock | 3,604 | 0.00 | — | 3,604 | — | ↗ |
| 2023-02-13 | McLaughlin Erica | Director | A-Award | A | Common Stock | 3,604 | 0.00 | — | 10,353 | — | ↗ |
| 2023-02-13 | MARTIN JOSEPH R | Director | A-Award | A | Common Stock | 5,268 | 0.00 | — | 92,957 | — | ↗ |
| 2023-02-13 | Davis Robyn C | Director | A-Award | A | Common Stock | 3,604 | 0.00 | — | 27,122 | — | ↗ |
| 2023-02-13 | Casal Frank | Director | A-Award | A | Common Stock | 3,604 | 0.00 | — | 5,789 | — | ↗ |
| 2023-02-03 | Nova Tina Susan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-01-31 | Zhou Ginger | Officer | A-Award | A | Common Stock | 323 | 46.92 | 15.2K | 8,814 | — | ↗ |
| 2023-01-31 | Vacha Robin | Officer | A-Award | A | Common Stock | 265 | 46.92 | 12.4K | 32,499 | — | ↗ |
| 2023-01-31 | Sriram Vandana | Officer | A-Award | A | Common Stock | 369 | 46.92 | 17.3K | 6,356 | — | ↗ |
| 2023-01-31 | Robertson Lindon G | Officer | A-Award | A | Common Stock | 279 | 46.92 | 13.1K | 117,458 | — | ↗ |
| 2023-01-31 | Crowley Kimberly | Officer | A-Award | A | Common Stock | 177 | 46.92 | 8.3K | 7,399 | — | ↗ |
| 2022-11-17 | Zhou Ginger | Officer | A-Award | A | Common Stock | 1,889 | 0.00 | — | 8,491 | — | ↗ |
| 2022-11-17 | Vacha Robin | Officer | A-Award | A | Common Stock | 3,778 | 0.00 | — | 32,234 | — | ↗ |
| 2022-11-17 | Sriram Vandana | Officer | A-Award | A | Common Stock | 2,519 | 0.00 | — | 5,987 | — | ↗ |
| 2022-11-17 | SCHWARTZ STEPHEN S | Officer | A-Award | A | Common Stock | 18,886 | 0.00 | — | 420,527 | — | ↗ |
| 2022-11-17 | Robertson Lindon G | Officer | A-Award | A | Common Stock | 6,296 | 0.00 | — | 117,179 | — | ↗ |
| 2022-11-17 | Joseph Jason | Officer | A-Award | A | Common Stock | 3,778 | 0.00 | — | 99,780 | — | ↗ |
| 2022-11-17 | Gray David C | Officer | A-Award | A | Common Stock | 3,148 | 0.00 | — | 92,219 | — | ↗ |
| 2022-11-17 | Crowley Kimberly | Officer | A-Award | A | Common Stock | 2,519 | 0.00 | — | 7,222 | — | ↗ |
| 2022-11-17 | Coyne Mitchell | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-11-15 | Zhou Ginger | Officer | — | D | Common Stock | 0 | 0.00 | — | 5,045 | — | ↗ |
| 2022-11-15 | Vacha Robin | Officer | A-Award | A | Common Stock | 11,077 | 0.00 | — | 34,294 | — | ↗ |
| 2022-11-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 81 | 0.00 | — | 3,468 | — | ↗ |
| 2022-11-15 | SCHWARTZ STEPHEN S | Officer | F-InKind | D | Common Stock | 26,293 | 0.00 | — | 401,641 | — | ↗ |
| 2022-11-15 | Robertson Lindon G | Officer | A-Award | A | Common Stock | 20,403 | 0.00 | — | 120,974 | — | ↗ |
| 2022-11-15 | Joseph Jason | Officer | F-InKind | D | Common Stock | 4,535 | 0.00 | — | 96,002 | — | ↗ |
| 2022-11-15 | Gray David C | Officer | F-InKind | D | Common Stock | 5,235 | 0.00 | — | 89,071 | — | ↗ |
| 2022-11-15 | Crowley Kimberly | Officer | F-InKind | D | Common Stock | 574 | 0.00 | — | 4,703 | — | ↗ |
| 2022-08-19 | Robertson Lindon G | Officer | P-Purchase | A | Common Stock | 4,350 | 57.62 | 250.6K | 100,571 | — | ↗ |
| 2022-08-19 | McManus Matthew | Officer | P-Purchase | A | COMMON | 8,625 | 58.15 | 501.5K | 29,467 | — | ↗ |
| 2022-07-29 | Sriram Vandana | Officer | A-Award | A | Common Stock | 292 | 57.49 | 16.8K | 3,549 | — | ↗ |
| 2022-07-29 | Robertson Lindon G | Officer | A-Award | A | Common Stock | 98 | 57.49 | 5.6K | 96,221 | — | ↗ |
| 2022-07-29 | De Jesus Linda | Officer | A-Award | A | Common | 43 | 57.49 | 2.5K | 2,764 | — | ↗ |
| 2022-07-29 | Crowley Kimberly | Officer | A-Award | A | Common Stock | 144 | 57.49 | 8.3K | 5,277 | — | ↗ |
| 2022-04-12 | Crowley Kimberly | Officer | S-Sale | D | Common Stock | 132 | 78.02 | 10.3K | 5,133 | — | ↗ |
| 2022-02-11 | Zane Ellen M | Director | A-Award | A | Common Stock | 1,922 | 0.00 | — | 56,296 | — | ↗ |
| 2022-02-11 | WRIGHTON MARK S | Director | A-Award | A | Common Stock | 1,922 | 0.00 | — | 111,818 | — | ↗ |
| 2022-02-11 | WOOLLACOTT ALFRED III | Director | A-Award | A | Restricted Stock | 1,922 | 0.00 | — | 6,554 | — | ↗ |
| 2022-02-11 | Rosenblatt Michael | Director | A-Award | A | Common Stock | 1,922 | 0.00 | — | 6,973 | — | ↗ |
| 2022-02-11 | Palepu Krishna G. | Director | A-Award | A | Common Stock | 1,922 | 0.00 | — | 101,789 | — | ↗ |
| 2022-02-11 | McLaughlin Erica | Director | A-Award | A | Common Stock | 1,922 | 0.00 | — | 6,749 | — | ↗ |
| 2022-02-11 | MARTIN JOSEPH R | Director | A-Award | A | Common Stock | 2,808 | 0.00 | — | 87,689 | — | ↗ |
| 2022-02-11 | Davis Robyn C | Director | A-Award | A | Common Stock | 1,922 | 0.00 | — | 23,518 | — | ↗ |
| 2022-02-11 | Casal Frank | Director | A-Award | A | Common Stock | 1,922 | 0.00 | — | 2,185 | — | ↗ |
| 2022-02-01 | Sriram Vandana | Officer | — | D | Common Stock | 0 | 0.00 | — | 3,257 | — | ↗ |
| 2022-01-31 | Vacha Robin | Officer | A-Award | A | Common Stock | 285 | 69.29 | 19.7K | 23,217 | — | ↗ |
| 2022-01-31 | Robertson Lindon G | Officer | J-Other | A | Common Stock | 189 | 69.29 | 13.1K | 96,123 | — | ↗ |
| 2022-01-31 | Crowley Kimberly | Officer | A-Award | A | Common Stock | 110 | 69.29 | 7.6K | 5,265 | — | ↗ |
| 2022-01-24 | McManus Matthew | Officer | — | D | Common Stock | 0 | 0.00 | — | 20,842 | — | ↗ |
| 2022-01-06 | MARTIN JOSEPH R | Director | G-Gift | D | Common Stock | 1,000 | 0.00 | — | 84,881 | — | ↗ |
| 2022-01-04 | De Jesus Linda | Officer | S-Sale | D | Common | 191 | 102.59 | 19.6K | 2,721 | — | ↗ |
| 2021-12-23 | Davis Robyn C | Director | A-Award | A | Restricted Stock Unit | 20 | 0.00 | — | 22,006 | — | ↗ |
| 2021-12-21 | WOOLLACOTT ALFRED III | Director | A-Award | A | Restricted Stock Unit | 4 | 0.00 | — | 4,632 | — | ↗ |
| 2021-11-19 | Jarzynka David | Officer | S-Sale | D | Common Stock | 10,216 | 120.29 | 1.23M | 46,315 | — | ↗ |
| 2021-11-18 | Vacha Robin | Officer | S-Sale | D | Common Stock | 6,490 | 119.03 | 772.5K | 22,932 | — | ↗ |
| 2021-11-18 | Gray David C | Officer | S-Sale | D | Common Stock | 4,049 | 118.48 | 479.7K | 84,106 | — | ↗ |
| 2021-11-17 | Vacha Robin | Officer | S-Sale | D | Common Stock | 1,549 | 119.27 | 184.7K | 29,422 | — | ↗ |
| 2021-11-17 | SCHWARTZ STEPHEN S | Director / Officer | S-Sale | D | Common Stock | 34,540 | 119.27 | 4.12M | 386,165 | — | ↗ |
| 2021-11-17 | Robertson Lindon G | Officer | S-Sale | D | Common Stock | 3,871 | 119.27 | 461.7K | 95,934 | — | ↗ |
| 2021-11-17 | Pietrantoni David | Officer | S-Sale | D | Common Stock | 832 | 119.27 | 99.2K | 27,375 | — | ↗ |
| 2021-11-17 | Joseph Jason | Officer | S-Sale | D | Common Stock | 1,561 | 119.27 | 186.2K | 89,850 | — | ↗ |
| 2021-11-17 | Jarzynka David | Officer | S-Sale | D | Common Stock | 2,161 | 119.27 | 257.7K | 56,531 | — | ↗ |
| 2021-11-17 | Gray David C | Officer | S-Sale | D | Common Stock | 1,163 | 119.27 | 138.7K | 88,151 | — | ↗ |
| 2021-11-15 | Vacha Robin | Officer | A-Award | A | Common Stock | 17,354 | 0.00 | — | 35,929 | — | ↗ |
| 2021-11-15 | SCHWARTZ STEPHEN S | Director / Officer | A-Award | A | Common Stock | 80,346 | 0.00 | — | 413,057 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | John Marotta President and Chief Executive Officer | 900.0K | — | 8.39M | — | 1.06M | 21.5K | 10.37M | 80.86% | ↗ |
| 2 | 2025 | Lawrence Lin Executive Vice President and and Chief Executive Officer | 463.2K | 250.0K | 2.78M | — | 398.1K | 13.8K | 3.91M | 71.22% | ↗ |
| 3 | 2025 | Ephraim Starr Senior Vice President, General Counsel/Corporate Secretary | 191.1K | — | 2.14M | — | 143.7K | 5.2K | 2.48M | 86.30% | ↗ |
| 4 | 2025 | Jason W. Joseph Former Senior Vice President, General Counsel/Corporate Secretary | 355.6K | — | 1.39M | — | 321.2K | 205.8K | 2.27M | 61.13% | ↗ |
| 5 | 2025 | Olga Pirogova Senior Vice President and Chief Human Resources Officer | 391.7K | — | 1.04M | — | 252.5K | 16.5K | 1.70M | 61.18% | ↗ |
| 6 | 2025 | Ginger Zhou Senior Vice President, President GENEWIZ | 410.1K | — | 867.6K | — | 261.4K | 9.2K | 1.55M | 56.03% | ↗ |
| 7 | 2025 | Herman Cueto Former Executive Vice President and Chief Financial Officer | 100.0K | 240.0K | — | — | — | 430.0K | 770.0K | 0.00% | ↗ |
| 8 | 2024 | Stephen S. Schwartz Former President and Chief Executive Officer | 755.4K | — | 4.90M | — | 407.7K | 61.4K | 6.12M | 80.01% | ↗ |
| 9 | 2024 | Herman Cueto Former Executive Vice President & Chief Financial Officer | 490.0K | 500.0K | 2.38M | — | 186.2K | 14.7K | 3.57M | 66.60% | ↗ |
| 10 | 2024 | Herman Cueto Former Executive Vice President and Chief Financial Officer | 490.0K | 500.0K | 2.38M | — | 186.2K | 14.7K | 3.57M | 66.60% | ↗ |
| 11 | 2024 | Jason W. Joseph Senior Vice President, General Counsel/Corporate Secretary | 454.6K | — | 1.80M | — | 140.4K | 13.1K | 2.41M | 74.75% | ↗ |
| 12 | 2024 | Jason W. Joseph Former Senior Vice President, General Counsel/Corporate Secretary | 454.6K | — | 1.80M | — | 140.4K | 13.1K | 2.41M | 74.75% | ↗ |
| 13 | 2024 | Ginger Zhou Senior Vice President & GM Multiomics | 386.5K | — | 1.05M | — | 123.4K | 14.0K | 1.57M | 66.71% | ↗ |
| 14 | 2024 | Ginger Zhou Senior Vice President, President GENEWIZ | 386.5K | — | 1.05M | — | 123.4K | 14.0K | 1.57M | 66.71% | ↗ |
| 15 | 2024 | David Wang Senior Vice President & GM Sample Management Solutions | 386.5K | — | 1.05M | — | 115.5K | 17.2K | 1.57M | 66.91% | ↗ |
| 16 | 2024 | Olga Pirogova Senior Vice President and Chief Human Resources Officer | 370.0K | — | 1.05M | — | 105.5K | 15.6K | 1.54M | 68.14% | ↗ |
| 17 | 2024 | John Marotta President and Chief Executive Officer | 34.6K | — | 604.2K | — | — | — | 638.8K | 94.58% | ↗ |
| 18 | 2024 | Lindon G. Robertson Former Executive Vice President and Chief Financial Officer | 212.0K | — | — | — | 201.9K | 13.2K | 427.1K | 0.00% | ↗ |
| 19 | 2023 | Stephen S. Schwartz President and Chief Executive Officer | 750.0K | — | 4.50M | — | 289.6K | 14.9K | 5.55M | 81.02% | ↗ |
| 20 | 2023 | Stephen S. Schwartz Former President and Chief Executive Officer | 750.0K | — | 4.50M | — | 289.6K | 14.9K | 5.55M | 81.02% | ↗ |
| 21 | 2023 | Lindon G. Robertson Former Executive Vice President and Chief Financial Officer | 525.0K | — | 1.50M | — | 184.3K | 14.9K | 2.22M | 67.44% | ↗ |
| 22 | 2023 | Jason W. Joseph Former Senior Vice President, General Counsel/Corporate Secretary | 431.9K | — | 900.0K | — | 98.5K | 13.7K | 1.44M | 62.32% | ↗ |
| 23 | 2023 | Jason W. Joseph Senior Vice President, General Counsel/Corporate Secretary | 431.9K | — | 900.0K | — | 98.5K | 13.7K | 1.44M | 62.32% | ↗ |
| 24 | 2023 | Robin Vacha Senior Vice President, Global Operations | 422.3K | — | 900.0K | — | 96.4K | 14.7K | 1.43M | 62.79% | ↗ |
| 25 | 2023 | David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 400.0K | — | 750.0K | — | 84.2K | 13.8K | 1.25M | 60.09% | ↗ |
| 26 | 2023 | Ginger Zhou Senior Vice President, President GENEWIZ | 323.1K | — | 450.1K | — | 70.9K | 5.0K | 849.0K | 53.01% | ↗ |
| 27 | 2023 | Ginger Zhou Senior Vice President & GM Multiomics | 323.1K | — | 450.1K | — | 70.9K | 5.0K | 849.0K | 53.01% | ↗ |
| 28 | 2023 | David Wang Senior Vice President & GM Sample Management Solutions | 265.9K | — | 320.9K | — | 49.0K | 10.8K | 646.5K | 49.63% | ↗ |
| 29 | 2023 | Olga Pirogova Senior Vice President and Chief Human Resources Officer | 25.6K | — | — | — | — | — | 25.6K | 0.00% | ↗ |
| 30 | 2022 | Stephen S. Schwartz President and Chief Executive Officer | 742.3K | — | 3.50M | — | 412.3K | 13.7K | 4.67M | 74.97% | ↗ |
| 31 | 2022 | Stephen S. Schwartz Former President and Chief Executive Officer | 742.3K | — | 3.50M | — | 412.3K | 13.7K | 4.67M | 74.97% | ↗ |
| 32 | 2022 | Matthew McManus Former Executive Vice President and Chief Operating Officer | 343.3K | 5.0K | 3.31M | — | 183.3K | 13.7K | 4.35M | 76.09% | ↗ |
| 33 | 2022 | Lindon G. Robertson Executive Vice President and Chief Financial Officer | 525.0K | 200.0K | 1.30M | — | 264.8K | 13.7K | 2.30M | 56.44% | ↗ |
| 34 | 2022 | Lindon G. Robertson Former Executive Vice President and Chief Financial Officer | 525.0K | 200.0K | 1.30M | — | 264.8K | 13.7K | 2.30M | 56.44% | ↗ |
| 35 | 2022 | Jason Joseph Senior Vice President, General Counsel/Corporate Secretary | 403.8K | 100.0K | 750.1K | — | 132.6K | 15.3K | 1.40M | 53.51% | ↗ |
| 36 | 2022 | Jason W. Joseph Senior Vice President, General Counsel/Corporate Secretary | 403.8K | 100.0K | 750.1K | — | 132.6K | 15.3K | 1.40M | 53.51% | ↗ |
| 37 | 2022 | Vandana Sriram Senior Vice President, Finance and Corporate Controller | 385.0K | 100.0K | 147.00 | — | 135.9K | 8.00 | 1.37M | 0.01% | ↗ |
| 38 | 2022 | Robin Vacha Senior Vice President, Global Operations | 410.4K | — | 800.1K | — | 59.7K | 13.6K | 1.28M | 62.32% | ↗ |
| 39 | 2022 | David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 395.4K | — | 650.1K | — | 119.8K | 13.5K | 1.18M | 55.15% | ↗ |
| 40 | 2022 | Ginger Zhou Senior Vice President & GM Multiomics | 299.2K | — | 200.1K | — | 69.8K | 6.7K | 575.9K | 34.75% | ↗ |
| 41 | 2021 | Stephen S. Schwartz President and Chief Executive Officer | 711.7K | — | 3.00M | — | 1.57M | 13.1K | 5.29M | 56.71% | ↗ |
| 42 | 2021 | Lindon G. Robertson Executive Vice President & Chief Financial Officer | 518.4K | — | 1.15M | — | 777.5K | 13.1K | 2.46M | 46.77% | ↗ |
| 43 | 2021 | Lindon G. Robertson Former Executive Vice President and Chief Financial Officer | 518.4K | — | 1.15M | — | 777.5K | 13.1K | 2.46M | 46.77% | ↗ |
| 44 | 2021 | Lindon G. Robertson Executive Vice President and Chief Financial Officer | 518.4K | — | 1.15M | — | 777.5K | 13.1K | 2.46M | 46.77% | ↗ |
| 45 | 2021 | David E. Jarzynka President, Brooks Semiconductor Solutions Group | 454.7K | — | 850.0K | — | 511.5K | 13.1K | 1.83M | 46.47% | ↗ |
| 46 | 2021 | Guojuan Liao Former President, Life Sciences Services | 454.7K | — | 850.0K | — | 455.9K | 13.1K | 1.77M | 47.93% | ↗ |
| 47 | 2021 | Robin Vacha Senior Vice President, Life Sciences Products | 386.7K | — | 750.0K | — | 377.1K | 14.4K | 1.53M | 49.08% | ↗ |
| 48 | 2021 | Robin Vacha Senior Vice President, Global Operations | 386.7K | — | 750.0K | — | 377.1K | 14.6K | 1.53M | 49.08% | ↗ |
| 49 | 2021 | Jason Joseph Senior Vice President, General Counsel/Corporate Secretary | 382.4K | — | 650.0K | — | 373.8K | 13.5K | 1.42M | 45.78% | ↗ |
| 50 | 2021 | Jason W. Joseph Senior Vice President, General Counsel/Corporate Secretary | 382.4K | — | 650.0K | — | 373.8K | 13.5K | 1.42M | 45.78% | ↗ |
| 51 | 2021 | David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 382.0K | — | 525.0K | — | 344.1K | 14.2K | 1.27M | 41.50% | ↗ |
| 52 | 2020 | Stephen S. Schwartz President and Chief Executive Officer | 675.0K | — | 2.50M | — | 729.7K | 12.8K | 3.92M | 63.82% | ↗ |
| 53 | 2020 | Lindon G. Robertson Executive Vice President & Chief Financial Officer | 500.0K | — | 1.05M | — | 491.4K | 12.8K | 2.05M | 51.12% | ↗ |
| 54 | 2020 | Lindon G. Robertson Executive Vice President and Chief Financial Officer | 500.0K | — | 1.05M | — | 491.4K | 12.8K | 2.05M | 51.12% | ↗ |
| 55 | 2020 | David E. Jarzynka President, Brooks Semiconductor Solutions Group | 440.0K | — | 850.0K | — | 317.5K | 12.8K | 1.62M | 52.46% | ↗ |
| 56 | 2020 | Guojuan Liao Former President, Life Sciences Services | 440.0K | — | 800.0K | — | 261.1K | 12.8K | 1.51M | 52.84% | ↗ |
| 57 | 2020 | Guojuan Liao President, Life Sciences Services | 440.0K | — | 800.0K | — | 261.1K | 12.8K | 1.51M | 52.84% | ↗ |
| 58 | 2020 | Jason W. Joseph Senior Vice President, General Counsel and Secretary | 360.6K | — | 600.0K | — | 212.9K | 13.0K | 1.19M | 50.57% | ↗ |
| 59 | 2020 | Jason Joseph Senior Vice President, General Counsel/Corporate Secretary | 360.6K | — | 600.0K | — | 212.9K | 13.0K | 1.19M | 50.57% | ↗ |
| 60 | 2020 | Robin Vacha Senior Vice President, Life Sciences Products | 350.0K | — | 570.0K | — | 56.8K | 12.7K | 989.5K | 57.60% | ↗ |
| 61 | 2019 | Stephen S. Schwartz President and Chief Executive Officer | 667.7K | — | 2.99M | — | 299.3K | 12.6K | 3.97M | 75.33% | ↗ |
| 62 | 2019 | Lindon G. Robertson Executive Vice President & Chief Financial Officer | 495.6K | — | 1.50M | — | 202.0K | 12.6K | 2.21M | 67.81% | ↗ |
| 63 | 2019 | Maurice H. Tenney III Former President, Brooks Life Sciences | 456.1K | — | 957.4K | — | — | 583.6K | 2.00M | 47.94% | ↗ |
| 64 | 2019 | Guojuan Liao Former President, Life Sciences Services | 366.4K | 64.0K | 957.4K | — | 255.7K | 15.4K | 1.66M | 57.71% | ↗ |
| 65 | 2019 | Guojuan Liao President, Life Sciences Services | 366.4K | 64.0K | 957.4K | — | 255.7K | 15.4K | 1.66M | 57.71% | ↗ |
| 66 | 2019 | Guojuan Liao President, GENEWIZ, Inc. | 366.4K | 64.0K | 957.4K | — | 255.7K | 15.4K | 1.66M | 57.71% | ↗ |
| 67 | 2019 | David E. Jarzynka President, Brooks Semiconductor Solutions Group | 422.5K | — | 957.4K | — | 87.7K | 13.4K | 1.48M | 64.65% | ↗ |
| 68 | 2019 | Jason W. Joseph Senior Vice President, General Counsel and Secretary | 345.6K | — | 758.2K | — | 84.4K | 12.8K | 1.20M | 63.13% | ↗ |
| 69 | 2019 | Robin Vacha Senior Vice President, Life Sciences Products | 335.4K | — | 540.0K | — | 246.9K | 14.0K | 1.14M | 47.53% | ↗ |
| 70 | 2019 | David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 370.6K | — | 628.3K | — | 90.6K | 13.9K | 1.10M | 56.94% | ↗ |
| 71 | 2018 | Stephen S. Schwartz President and Chief Executive Officer | 643.8K | — | 2.22M | — | 1.05M | 12.4K | 3.93M | 56.48% | ↗ |
| 72 | 2018 | Lindon G. Robertson Executive Vice President & Chief Financial Officer | 473.8K | — | 1.06M | — | 614.3K | 12.4K | 2.16M | 49.09% | ↗ |
| 73 | 2018 | Maurice H. Tenney III Former President, Brooks Life Sciences | 457.5K | — | 909.6K | — | 321.8K | 12.4K | 1.70M | 53.47% | ↗ |
| 74 | 2018 | Maurice H. Tenney III President, Brooks Life Sciences | 457.5K | — | 909.6K | — | 321.8K | 12.4K | 1.70M | 53.47% | ↗ |
| 75 | 2018 | David E. Jarzynka President, Brooks Semiconductor Solutions Group | 372.5K | — | 667.0K | — | 396.3K | 13.8K | 1.45M | 46.01% | ↗ |
| 76 | 2018 | David E. Jarzynka President , Brooks Semiconductor Solutions Group | 372.5K | — | 667.0K | — | 396.3K | 13.8K | 1.45M | 46.01% | ↗ |
| 77 | 2018 | David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 357.5K | — | 545.7K | — | 278.2K | 12.5K | 1.19M | 45.71% | ↗ |
| 78 | 2018 | Jason W. Joseph Senior Vice President, General Counsel and Secretary | 330.7K | — | 545.7K | — | 257.7K | 11.7K | 1.15M | 47.63% | ↗ |
| 79 | 2017 | Stephen S. Schwartz President and Chief Executive Officer | 625.0K | — | 2.06M | — | 1.20M | 12.2K | 3.89M | 52.95% | ↗ |
| 80 | 2017 | Lindon G. Robertson Executive Vice President & Chief Financial Officer | 436.3K | — | 908.2K | — | 597.6K | 12.2K | 1.95M | 46.48% | ↗ |
| 81 | 2017 | Lindon G. Robertson Executive Vice President | 436.3K | — | 908.2K | — | 597.6K | 12.2K | 1.95M | 46.48% | ↗ |
| 82 | 2017 | Maurice H. Tenney III President, Brooks Life Sciences | 432.5K | 100.0K | 891.5K | — | 236.5K | 12.2K | 1.67M | 53.30% | ↗ |
| 83 | 2017 | Maurice H. Tenney III Former President, Brooks Life Sciences | 432.5K | 100.0K | 891.5K | — | 236.5K | 12.2K | 1.67M | 53.30% | ↗ |
| 84 | 2017 | David E. Jarzynka President, Brooks Semiconductor Solutions Group | 346.3K | — | 626.9K | — | 359.6K | 12.7K | 1.35M | 46.59% | ↗ |
| 85 | 2017 | David E. Jarzynka President , Brooks Semiconductor Solutions Group | 346.3K | — | 626.9K | — | 359.6K | 12.7K | 1.35M | 46.59% | ↗ |
| 86 | 2017 | David E. Jarzynka Senior Vice President Solutions Group | 346.3K | — | 626.9K | — | 359.6K | 12.7K | 1.35M | 46.59% | ↗ |
| 87 | 2017 | David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 350.0K | — | 487.6K | — | 287.7K | 12.1K | 1.14M | 42.87% | ↗ |
| 88 | 2017 | Brooks Semiconductor David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 350.0K | — | 487.6K | — | 287.7K | 12.1K | 1.14M | 42.87% | ↗ |
| 89 | 2016 | Stephen S. Schwartz President and Chief Executive Officer | 625.0K | — | 1.76M | — | 490.6K | 12.4K | 2.89M | 60.95% | ↗ |
| 90 | 2016 | Mark D. Morelli Former President & Chief Operating Officer | 267.3K | — | 1.02M | — | 186.1K | 521.8K | 2.00M | 51.18% | ↗ |
| 91 | 2016 | Maurice H. Tenney III President, Brooks Life Sciences | 425.0K | — | 908.8K | — | 214.9K | 108.2K | 1.66M | 54.85% | ↗ |
| 92 | 2016 | Maurice H. Tenney III President, Brooks | 425.0K | — | 908.8K | — | 214.9K | 108.2K | 1.66M | 54.85% | ↗ |
| 93 | 2016 | Lindon G. Robertson Executive Vice President | 425.0K | — | 795.2K | — | 314.5K | 113.5K | 1.65M | 48.25% | ↗ |
| 94 | 2016 | Lindon G. Robertson Executive Vice President & Chief Financial Officer | 425.0K | — | 795.2K | — | 314.5K | 113.5K | 1.65M | 48.25% | ↗ |
| 95 | 2016 | David E. Jarzynka President , Brooks Semiconductor Solutions Group | 319.2K | — | 798.3K | — | 188.0K | 12.8K | 1.32M | 60.55% | ↗ |
| 96 | 2016 | Life Sciences David E. Jarzynka Senior Vice President Solutions Group | 319.2K | — | 798.3K | — | 188.0K | 12.8K | 1.32M | 60.55% | ↗ |
| 97 | 2016 | David E. Jarzynka Senior Vice President Solutions Group | 319.2K | — | 798.3K | — | 188.0K | 12.8K | 1.32M | 60.55% | ↗ |
| 98 | 2016 | David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 350.0K | — | 511.2K | — | 157.5K | 12.0K | 1.03M | 49.60% | ↗ |
| 99 | 2016 | Brooks Semiconductor David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 350.0K | — | 511.2K | — | 157.5K | 12.0K | 1.03M | 49.60% | ↗ |
| 100 | 2015 | Stephen S. Schwartz Chief Executive Officer | 625.0K | — | 1.91M | — | 531.8K | 13.9K | 3.08M | 62.01% | ↗ |
| 101 | 2015 | Stephen S. Schwartz President and Chief Executive Officer | 625.0K | — | 1.91M | — | 531.8K | 13.9K | 3.08M | 62.01% | ↗ |
| 102 | 2015 | Maurice H. Tenney President, Brooks Life Sciences | 376.0K | 175.0K | 2.09M | — | 102.2K | 12.8K | 2.76M | 75.87% | ↗ |
| 103 | 2015 | Maurice H. Tenney III President, Brooks Life Sciences | 376.0K | — | 2.09M | — | 102.2K | 12.8K | 2.59M | 81.01% | ↗ |
| 104 | 2015 | Maurice H. Tenney III President, Brooks | 376.0K | — | 2.09M | — | 102.2K | 12.8K | 2.59M | 81.01% | ↗ |
| 105 | 2015 | Mark D. Morelli President Chief Operating Officer | 500.0K | — | 1.19M | — | 425.0K | 11.5K | 2.13M | 56.04% | ↗ |
| 106 | 2015 | Mark D. Morelli Former President & Chief Operating Officer | 500.0K | — | 1.19M | — | 425.0K | 11.5K | 2.13M | 56.04% | ↗ |
| 107 | 2015 | Lindon G. Robertson Executive Vice | 425.0K | — | 895.5K | — | 361.3K | 76.8K | 1.76M | 50.92% | ↗ |
| 108 | 2015 | Lindon G. Robertson Executive Vice President | 425.0K | — | 895.5K | — | 361.3K | 76.8K | 1.76M | 50.92% | ↗ |
| 109 | 2015 | Brooks Semiconductor David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 350.0K | — | 501.5K | — | 178.5K | 21.1K | 1.05M | 47.71% | ↗ |
| 110 | 2015 | David C. Gray Senior Vice President, Chief Strategy and New | 350.0K | — | 501.5K | — | 178.5K | 21.1K | 1.05M | 47.71% | ↗ |
| 111 | 2014 | Stephen S. Schwartz President and Chief Executive Officer | 611.2K | — | 1.51M | — | 671.1K | 76.6K | 2.87M | 52.67% | ↗ |
| 112 | 2014 | Stephen S. Schwartz Chief Executive Officer | 611.2K | — | 1.51M | — | 671.1K | 76.6K | 2.87M | 52.67% | ↗ |
| 113 | 2014 | Lindon G. Robertson Executive Vice | 415.2K | — | 1.27M | — | 455.9K | 73.6K | 2.22M | 57.37% | ↗ |
| 114 | 2014 | Lindon G. Robertson Executive Vice President Chief Financial Officer | 415.2K | — | 1.27M | — | 455.9K | 73.6K | 2.22M | 57.37% | ↗ |
| 115 | 2014 | Lindon G. Robertson Executive Vice President | 415.2K | — | 1.27M | — | 455.9K | 73.6K | 2.22M | 57.37% | ↗ |
| 116 | 2014 | Mark D. Morelli President Chief Operating Officer | 479.2K | — | 1.04M | — | 526.2K | 11.5K | 2.06M | 50.55% | ↗ |
| 117 | 2014 | Mark D. Morelli Former President & Chief Operating Officer | 479.2K | — | 1.04M | — | 526.2K | 11.5K | 2.06M | 50.55% | ↗ |
| 118 | 2014 | David C. Gray Senior Vice President, Chief Strategy and New | 336.9K | — | 741.0K | — | 230.6K | 1.8K | 1.31M | 56.55% | ↗ |
| 119 | 2014 | Brooks Semiconductor David C. Gray Senior Vice President, Chief Strategy and New Business Officer | 336.9K | — | 741.0K | — | 230.6K | 1.8K | 1.31M | 56.55% | ↗ |
| 120 | 2014 | David C. Gray Senior Vice President, Chief Strategy and New | 336.9K | — | 741.0K | — | 230.6K | 1.8K | 1.31M | 56.55% | ↗ |
| 121 | 2014 | William T. Montone | 257.2K | — | 425.3K | — | 169.5K | 29.7K | 881.6K | 48.23% | ↗ |
| 122 | 2013 | Stephen S. Schwartz Chief Executive Officer | 536.3K | — | 1.23M | — | 125.0K | 86.5K | 1.97M | 62.13% | ↗ |
| 123 | 2013 | Martin S. Headley Executive Vice President Chief Financial Officer (former) | 396.4K | — | 572.6K | — | — | 810.0K | 1.78M | 32.19% | ↗ |
| 124 | 2013 | Mark D. Morelli President Chief Operating Officer | 396.4K | — | 818.0K | — | 106.3K | 69.2K | 1.39M | 58.86% | ↗ |
| 125 | 2013 | Clinton M. Haris Senior Vice President of Brooks Life Science Systems | 256.5K | — | 286.3K | — | 69.0K | 49.4K | 661.2K | 43.30% | ↗ |
| 126 | 2013 | Thomas R. Leitzke Senior Vice President, Global Operations (former) | 266.0K | — | 327.2K | — | 16.8K | 29.2K | 639.2K | 51.19% | ↗ |
| 127 | 2012 | Stephen S. Schwartz Chief Executive Officer | 575.0K | — | 3.74M | — | 103.5K | 38.3K | 4.46M | 83.92% | ↗ |
| 128 | 2012 | Stephen S. Schwartz President Chief Executive Officer | 575.0K | — | 3.74M | — | 103.5K | 38.3K | 4.46M | 83.92% | ↗ |
| 129 | 2012 | Mark D. Morelli President Chief Operating Officer | 310.6K | — | 2.22M | — | 85.0K | 58.9K | 2.67M | 82.98% | ↗ |
| 130 | 2012 | Mark D. Morelli Executive Vice President Chief Operating Officer | 310.6K | — | 2.22M | — | 85.0K | 58.9K | 2.67M | 82.98% | ↗ |
| 131 | 2012 | Martin S. Headley Executive Vice President Chief Financial Officer | 425.0K | — | 1.76M | — | 68.0K | 27.7K | 2.28M | 77.21% | ↗ |
| 132 | 2012 | Martin S. Headley Executive Vice President Chief Financial Officer (former) | 425.0K | — | 1.76M | — | 68.0K | 27.7K | 2.28M | 77.21% | ↗ |
| 133 | 2012 | Thomas R. Leitzke Senior Vice President, Global Operations | 280.0K | — | 748.3K | — | 33.6K | 49.5K | 1.11M | 67.33% | ↗ |
| 134 | 2012 | Thomas R. Leitzke Senior Vice President, Global Operations (former) | 280.0K | — | 748.3K | — | 33.6K | 49.5K | 1.11M | 67.33% | ↗ |
| 135 | 2012 | Steven A. Michaud Senior Vice President, Executive Strategy | 315.0K | — | 641.4K | — | 35.4K | 35.3K | 1.06M | 60.53% | ↗ |
| 136 | 2012 | Clinton M. Haris Senior Vice President of Brooks Life Science Systems | 270.0K | — | 641.4K | — | 56.7K | 39.8K | 1.01M | 63.64% | ↗ |
| 137 | 2011 | Stephen S. Schwartz President Chief Executive Officer | 563.5K | — | 2.74M | — | 525.0K | 33.5K | 3.86M | 70.93% | ↗ |
| 138 | 2011 | Stephen S. Schwartz Chief Executive Officer | 563.5K | — | 2.74M | — | 525.0K | 33.5K | 3.86M | 70.93% | ↗ |
| 139 | 2011 | Martin S. Headley Executive Vice President Chief Financial Officer | 425.0K | — | 743.4K | — | 407.6K | 11.0K | 1.59M | 46.84% | ↗ |
| 140 | 2011 | Martin S. Headley Executive Vice President Chief Financial Officer (former) | 425.0K | — | 743.4K | — | 407.6K | 11.0K | 1.59M | 46.84% | ↗ |
| 141 | 2011 | Martin S. Headley | 425.0K | — | — | — | — | — | 1.59M | 0.00% | ↗ |
| 142 | 2011 | Steven A. Michaud Senior Vice President, Executive Strategy | 311.0K | — | — | — | — | — | 831.9K | 0.00% | ↗ |
| 143 | 2011 | Steven A. Michaud Senior Vice President, Executive Strategy | 311.0K | — | 322.1K | — | 168.8K | 16.3K | 831.9K | 38.72% | ↗ |
| 144 | 2011 | Thomas R. Leitzke Senior Vice President, Global Operations (former) | 271.9K | — | 309.8K | — | 149.6K | 69.0K | 800.3K | 38.70% | ↗ |
| 145 | 2011 | Thomas R. Leitzke Senior Vice President, Global Operations | 271.9K | — | 309.8K | — | 149.6K | 69.0K | 800.3K | 38.70% | ↗ |
| 146 | 2011 | Thomas R. Leitzke Senior Vice President, Global Operations (former) | 271.9K | — | — | — | — | — | 800.3K | 0.00% | ↗ |
| 147 | 2011 | Clinton M. Haris Senior Vice President of Brooks Life Science Systems | 257.9K | — | 272.6K | — | 156.2K | 37.1K | 723.8K | 37.66% | ↗ |
| 148 | 2011 | Clinton M. Haris Senior Vice President, Brooks Life Science Systems | 257.9K | — | — | — | — | — | 720.5K | 0.00% | ↗ |
| 149 | 2010 | Stephen S. Schwartz President Chief Executive Officer | 240.4K | — | 1.89M | — | 250.0K | 69.5K | 2.45M | 77.13% | ↗ |
| 150 | 2010 | Stephen S. Schwartz President Chief Executive Officer | 240.4K | — | 1.89M | — | 250.0K | 69.5K | 2.45M | 77.13% | ↗ |
| 151 | 2010 | Martin S. Headley Executive Vice President Chief | 413.7K | — | 1.02M | — | 505.3K | 11.8K | 1.95M | 52.22% | ↗ |
| 152 | 2010 | Martin S. Headley Executive Vice President Chief Financial Officer | 413.7K | — | 1.02M | — | 505.3K | 11.8K | 1.95M | 52.22% | ↗ |
| 153 | 2010 | Robert J. Lepofsky President Chief Executive Officer | 623.5K | — | — | — | 650.0K | 16.3K | 1.29M | 0.00% | ↗ |
| 154 | 2010 | Steven A. Michaud Senior Vice President, Executive Strategy | 292.0K | — | 702.0K | — | 180.0K | 19.4K | 1.20M | 58.27% | ↗ |
| 155 | 2010 | Steven A. Michaud Senior Vice President Group | 292.0K | — | 702.0K | — | 180.0K | 19.4K | 1.20M | 58.27% | ↗ |
| 156 | 2010 | Clinton M. Haris Senior Vice President, Brooks Life Science Systems | 216.1K | — | — | — | — | — | 1.04M | 0.00% | ↗ |
| 157 | 2010 | Clinton M. Haris Senior Vice President, Brooks Life Science Systems | 216.1K | — | 650.9K | — | 135.0K | 10.0K | 1.04M | 62.87% | ↗ |
| 158 | 2009 | Robert J. Lepofsky President Chief | 597.1K | — | — | — | — | — | 3.17M | 0.00% | ↗ |
| 159 | 2009 | Robert J. Lepofsky President Chief Executive Officer | 597.1K | — | 2.44M | — | — | 7.2K | 3.04M | 80.12% | ↗ |
| 160 | 2009 | Martin S. Headley Executive Vice President Chief | 403.4K | — | 810.0K | — | — | 79.4K | 1.29M | 62.66% | ↗ |
| 161 | 2009 | Martin S. Headley Executive Vice | 403.4K | — | — | — | — | — | 1.17M | 0.00% | ↗ |
| 162 | 2009 | Steven A. Michaud Senior Vice | 277.0K | — | — | — | — | — | 739.1K | 0.00% | ↗ |
| 163 | 2009 | Steven A. Michaud Senior Vice President Group | 277.0K | — | 333.2K | — | — | 22.1K | 632.3K | 52.70% | ↗ |
| 164 | 2009 | Thomas S. Grilk Senior Vice President, General Counsel | 296.9K | — | — | — | — | — | 596.3K | 0.00% | ↗ |
| 165 | 2009 | Timothy S. Mathews | 190.6K | — | — | — | — | — | 328.9K | 0.00% | ↗ |
| 166 | 2008 | Robert J. Lepofsky President Chief Executive Officer | 650.0K | — | 3.74M | — | — | 10.0K | 4.40M | 85.00% | ↗ |
| 167 | 2008 | Robert J. Lepofsky President Chief | 650.0K | — | — | — | — | — | 2.59M | 0.00% | ↗ |
| 168 | 2008 | Martin S. Headley Executive Vice President Chief | 269.7K | — | 472.5K | — | 215.0K | 207.4K | 1.16M | 40.57% | ↗ |
| 169 | 2008 | Martin S. Headley Executive Vice | 269.7K | — | — | — | — | — | 793.4K | 0.00% | ↗ |
| 170 | 2008 | Steven A. Michaud Senior Vice | 244.6K | — | — | — | — | — | 661.7K | 0.00% | ↗ |
| 171 | 2008 | Steven A. Michaud Senior Vice President Group | 244.6K | — | 186.3K | — | 150.0K | 22.8K | 603.7K | 30.86% | ↗ |
| 172 | 2008 | Thomas S. Grilk Senior Vice President, General Counsel | 306.7K | — | — | — | — | — | 529.2K | 0.00% | ↗ |
| 173 | 2008 | Thomas S. Grilk Senior Vice President, | — | — | — | — | — | — | — | — | ↗ |
| 174 | 2008 | Steven A. Michaud | — | — | — | — | — | — | — | — | ↗ |
| 175 | 2008 | Robert W. Woodbury, Jr. Former Executive Vice | — | — | — | — | — | — | — | — | ↗ |
| 176 | 2008 | Michael W. Pippins | — | — | — | — | — | — | — | — | ↗ |
| 177 | 2008 | Martin S. Headley | — | — | — | — | — | — | — | — | ↗ |
| 178 | 2008 | Robert J. Lepofsky | — | — | — | — | — | — | — | — | ↗ |
| 179 | 2007 | Edward C. Grady | 600.0K | — | 1.77M | — | 464.4K | 202.1K | 3.24M | 54.65% | ↗ |
| 180 | 2007 | Joseph M. Bellini | 191.3K | — | 86.1K | — | 625.0K | 681.6K | 1.65M | 5.23% | ↗ |
| 181 | 2007 | James F. Gentilcore | 408.8K | — | 225.0K | — | 316.0K | 167.1K | 1.48M | 15.18% | ↗ |
| 182 | 2007 | Robert E. Anastasi | 306.7K | — | 152.3K | — | 174.8K | 345.9K | 1.23M | 12.35% | ↗ |
| 183 | 2007 | Robert W. Woodbury, Jr. | 313.9K | — | 450.0K | — | 256.8K | 76.7K | 1.15M | 39.10% | ↗ |
| 184 | 2007 | Thomas S. Grilk Senior Vice President, General Counsel | 296.4K | — | — | — | — | — | 656.2K | 0.00% | ↗ |
| 185 | 2007 | Thomas S. Grilk Senior Vice President, General Counsel | 296.4K | — | 120.6K | — | 169.5K | 44.8K | 656.2K | 18.37% | ↗ |
| 186 | 2007 | Thomas S. Grilk Senior Vice President, | — | — | — | — | — | — | — | — | ↗ |
| 187 | 2007 | Robert W. Woodbury, Jr. Former Executive Vice | — | — | — | — | — | — | — | — | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| John Marotta | President, Chief Executive Officer & Director | 2M | male |
| Lawrence Y. Lin | Executive Vice President & Chief Financial Officer | 1M | male |
| Ginger Zhou | Advisor | 680.8K | — |
| Olga Pirogova | Senior Vice President & Chief HR Officer | 660.7K | female |
| Ephraim Starr | Senior Vice President, General Counsel & Corporate Secretary | 653.9K | male |
| Yvonne Perron | Vice President of Financial Planning & Analysis and Investor Relations | — | female |
| Andrea O'Hara | Strategic Technical Specialist of Azenta Life Sciences | — | — |
| Michael Paulo | Vice President, Chief Information & Digital Officer | — | male |
| William E. Martin | President of Multiomics Business | — | male |
| Alex Esmon | Vice President and General Manager of Sample Repository Solutions | — | male |
No Senate trading activity found for this company.
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-04-08 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2026-01-15 | 2026-02-13 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-09 | 2025-11-18 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-03-19 | 2025-04-11 | Josh Gottheimer | NJ05 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-09-15 | 2023-10-15 | Josh Gottheimer | NJ05 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-07-14 | 2023-08-21 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2023-06-13 | 2023-07-11 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2021-12-15 | 2022-01-10 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2021-12-03 | 2022-01-10 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AZTA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
